Jianjun Peng, Jianjun Xiao, Jianting Long, Ling Huang, Yong Li, Jianhua Liu, Haibo Zhang, Derong Xie, Wei Wang, Chengyin Weng, Zongcheng Zhang, Xiaoshu Chai. "Updated analysis of a phase 2 study of fruquintinib plus trifluridine/tipiracil (TAS-102) as third-line treatment in patients with metastatic colorectal adenocarcinoma.." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.4_suppl.145